"10.1371_journal.pone.0060420","plos one","2013-04-02T00:00:00Z","Steven K Hildemann; Jens Eberlein; Bennett Davenport; Tom T Nguyen; Francisco Victorino; Dirk Homann","University Clinic for Cardiology and Angiology I, University Heart Center, Freiburg-Bad Krozingen, Germany; Merck Research Laboratories/MSD Global Clinical Trial Operations, Haar, Germany; Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, Aurora, Colorado, United States of America; Integrated Department of Immunology, University of Colorado Denver and National Jewish Health, Denver, Colorado, United States of America; Department of Anesthesiology, University of Colorado Denver, Aurora, Colorado, United States of America","Conceived and designed the experiments: DH. Performed the experiments: JE BD TTN FV DH. Analyzed the data: JE BD DH. Wrote the paper: SKH DH.","The authors have the following interests. SKH leads the clinical research operations of MSD/Merck in Europe and is a full time employee of MSD/Merck. The current work is unrelated to any preclinical or clinical research ongoing at Merck and has received no financial or other support from MSD/Merck. Dirk Homann is a PLOS ONE Editorial Board member. There are no patents, products in development or marketed products to declare. This does not alter the authorsâ€™ adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2013","04","Steven K Hildemann","SKH",6,TRUE,1,5,3,2,TRUE,FALSE,FALSE,0,NA,FALSE
